Financials

  • Market Capitalization 1.9 B
  • Employee 87
  • Founded 2018
  • CEO N/A
  • Website www.tyra.bio
  • Headquarter Delaware, United States
  • FIGI BBG00RCQD9D1
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1992
GLUE
Monte Rosa Therapeutics, Inc. - Common Stock
23.20 USD-1.11%-4.41%+28.60%+105.31%1.96 B USD
1997
VRDN
Viridian Therapeutics, Inc. - Common Stock
18.98 USD-0.52%-5.01%+16.51%-15.46%1.96 B USD
2012
SION
Sionna Therapeutics, Inc. - Common Stock
42.39 USD-0.47%-8.13%+17.72%+7.75%1.91 B USD
2025
URGN
UroGen Pharma Ltd. - Ordinary Shares
38.50 USD-1.76%+2.31%+25.61%+102.63%1.88 B USD

Nouvelles